JBusch - Emerging Growth Stocks

EMERGING GROWTH STOCKS | Updated: 08‐Aug‐16
Rankings for 8/8/16 (AHS ANIP CARB EBIX GORO HBP IBP MGNX PE SODA XNCR YNDX etc)
Emerging Growth Stocks is Briefing.com's proprietary quantitative system designed to uncover small, fast‐growing companies
that have the potential to become market leaders.
Summary & Notes:
Last week over 1,000 companies reported earnings, leading to some significant turnover in our rankings (8 new additions
and 9 deletions).
The Q2 earnings season wraps up this week ‐‐ in fact the number of companies on the calendar falls off a cliff after
Tuesday. So we would expect 1‐2 more weeks of elevated turnover as the final stragglers report and as stocks further
extend their earnings‐related moves.
Otherwise, not much has changed sentiment‐wise: the tone of the Q2 reporting season was quite positive, and while
some profit‐taking has set in, the market advance remains very broad‐based, with both high‐multiple growth stocks
participating alongside value names.
If you're new to this page, each Monday we publish an updated list of the top 25 small‐ and mid‐cap growth stocks in the
market. These companies are discovered and ranked using a quantitative screen that removes emotion and bias from the process, and which places a heavy
emphasis on current and forward‐looking indicators such as strong 6‐month Relative Strength, fast‐growing quarterly sales and EPS, expanding margins, etc. In
addition, on the Live In Play page our analysts periodically publish fundamental and technical commentary under the "GROWX" ticker on EG components that have
significant news, notable technical characteristics, or are just names that we find interesting.
We'd like to emphasize that the EG system was created in order to generate new growth stock ideas every week, regardless of market conditions. As such,
readers should understand that Emerging Growth was specifically designed to be an idea generation system, and not a portfolio timing system.
If you have any questions or feedback regarding Emerging Growth Stocks, please contact us at emerginggrowth@briefing.com.
* * *
We have eight new additions to the Top 25 this week:
Gold Resource (GORO #2) is a gold and silver producer with operations in Oaxaca, Mexico and exploration in Nevada, USA. It focuses on projects that feature low
operating costs, which appears to have helped it keep a debt‐free balance sheet. GORO has a 100% interest in six potential high‐grade gold and silver properties at
its producing Oaxaca, Mexico Mining Unit and exploration properties at its Nevada Mining Unit. What’s a bit unusual about GORO is that it offers shareholders the
option to convert their cash dividends into physical gold and silver and take delivery. GORO’s stock price has been very strong since mid‐January. After a difficult
2015, commodity prices for silver and gold have improved quite a bit in 2016 due to rising geopolitical risk and the Fed sounding cautious about raising rates. This
has led to higher precious metal prices. On August 2, GORO reported solid Q2 results, boosted by higher gold and silver prices. In 1H16, GORO produced 16,474
ounces of gold and 1,006,640 ounces of silver. Also, GORO maintained its 2016 annual outlook of 26,000 gold ounces, 1,900,000 silver ounces, 1,100 tons of copper,
3,200 tons of lead and 12,900 tons of zinc.
Sodastream (SODA #6) is the world’s largest manufacturer of home beverage carbonation systems. After being seen as a hot growth stock in 2013 with the potential
to replicate its success in Europe in order to revolutionize the US carbonated soda market, the stock fell from $78 in mid‐2013 to as low as $12 as recently as
February 2016. It turned out that US consumers did not want to make their soda at home. SODA was hurt by evolving consumers’ taste away from sugary sodas and
it was hurt because SODA’s soda just didn’t taste that good. In response, SODA recently made a big change: it repositioned itself as a sparkling water brand. Its re‐
named Sparkling Water Makers enable consumers to easily transform ordinary tap water into sparkling (carbonated) water and flavored sparkling water in seconds.
SODA’s at‐home system offers advantages: 1) Convenience (no heavy bottles or 12‐packs, saves space, no empties to recycle), 2) Cost effective (saves up to 70% for
sparking water), 3) Healthier Alternative (no high fructose corn syrup) and 4) Environmentally friendly (avoids pollution from discarded cans and bottles). Investors
like the repositioning of the brand as the stock has more than doubled since the February lows. A huge Q2 beat in early August is good evidence that the new
strategy is resonating with consumers.
Xencor (XNCR #8) is a biotech that uses its proprietary XmAb antibody engineering platform to develop drug candidates to treat autoimmune disorders, cancer,
asthma, and allergic diseases. Basically, it's a platform company that is both developing its own therapeutics and licenses out its technology to larger biopharmas.
XNCR's platform works by altering the Fc domain, which is the stem of the antibody structure that's responsible for its natural immune functions. The resulting
XmAb Fc domains can then be substituted into nearly any antibody in order to enhance natural functions or to create entirely new mechanisms of action. The
company claims that the "plug‐and‐play" nature of its XmAb technology enables the rapid creation of more powerful and effective antibodies. XNCR's most advanced
drug candidates are both in Phase 2 trials: XmAb5871 for IgG4‐RD and XmAb5574 for asthma/allergy. Prominent partners include Amgen, Novo Nordisk, Janssen,
Merck, MorphoSys, Boehringer Ingelheim, and Alexion. On June 28 a major catalyst occured when XNCR announced a worldwide collaboration agreement with
Novartis to jointly develop XmAb14045 and XmAb13676 (both preclinical). Under the terms of the deal, NVS receives ex‐US rights to the two drug candidates, while
XNCR retains full US rights; NVS also receives rights to develop additional targets. Financially, this is a lucrative deal for XNCR, as it includes an upfront payment of
$150 mln, $2.4 bln in potential milestones, and royalty payments on ex‐US sales. Q2 earnings on August 2 showed a huge jump in sales and a surprise profit, but this
was entirely due to the one‐time upfront NVS payment. The stock still jumped on the report however, as management provided more color on the NVS partnership
and noted that they now have enough cash to fund operations through "at least the end of 2019" ‐‐ the year that XmAb5871 for IgG4‐RD is expected to be
commercialized (if approved). Note that XNCR is expect to revert back to reporting a loss in Q3, which would automatically remove it from our rankings.
Carbonite (CARB #9) provides online data backup for consumers and small‐ and medium‐sized businesses (SMBs). CARB went public in 2011 as a fast‐growing but
unprofitable company. At the time, most of their business was on the consumer side, which was marked by cut‐throat competition based largely on price (they
launched their SMB offering just a year before their IPO). Not surprisingly, as competition intensified and pricing pressures mounted, CARB decided to focus on the
SMB side. In December 2015 the company accelerated this process by acquiring Seagate's EVault business, which provided cloud‐based data protection & back‐up
Copyright © 2016 Briefing.com, Inc. All rights reserved. 1 of 9

for mid‐sized businesses. At a purchase price of $14 mln, the deal was accretive, added 5,000 customers in North America and Europe, expanded their TAM, and
provided CARB with new technology and numerous patents. In particular, EVault's Disaster Recovery as a Service (DRaaS) was cited as a key growth asset. As it
stands now, management sees their gradually declining consumer biz as a cash cow that helps fund their much faster‐growing SMB segment. Interestingly, CARB saw
quite a bit of success in Q1 marketing themselves as something of a security company, specifically targeting customers who were attacked with "ransomware,"
which is an attack where hackers send a virus that steals data, encrypts the files, and then they demand payment to unlock the files. On August 2, the company
reported very strong Q2 results, with impressive beats on the top‐ and bottom‐lines and upside guidance. The higher‐margin SMB segment continues to drive
growth and operating leverage.
ANI Pharmaceuticals (ANIP #10) is a specialty pharma company that has built itself up through a series of accretive product acquisitions. The company focuses on
niche and high‐barrier to entry targets in areas such as controlled substances, oncology, hormones & steroids, and complex formulations. Roughly 70% of sales come
from generics, 24% from branded products, and <5% from contract manufacturing. ANIP currently has 81 products in development targeting an estimated total
current market of $4.1 billion. On August 4 the company reported very strong Q2 results and raised its 2016 guidance. Management attributed the strong Q2
performance to several new product launches. Looking ahead, while acquisitions will be a key component of the company's growth strategy, management cited the
July launch of its generic anti‐cancer product and the anticipated launch of its anti‐infective product as key drivers for Q3; they also reiterated their expectation
that revenues and EBITDA will continue to grow sequentially through 2016 due to new product launches.
MacroGenics (MGNX #17) is a clinical‐stage biopharma focused on developing monoclonal antibody‐based therapeutics for the treatment of cancer and autoimmune
diseases. The company's proprietary technologies include its Dual Affinity Re‐Targeting (DART) platform, which has produced six molecules that are being evaluated
in clinical studies, and its Fc Optimization platform (which takes a similar approach as XNCR's platform, above). MGNX's most advanced product candidate is
margetuximab, which is in trials for two separate indications: HER2‐positive metastatic breast cancer (just beginning Phase 3) and gastric cancer (Phase 1b/2). The
company also has multiple product candidates from its DART platform and its B7‐H3 franchise that are in pre‐clinical and Phase 1 studies. The company has
partnerships with Pfizer, Boehringer Ingelheim, Gilead Sciences, and Takeda. Recently, on May 18 MGNX announced a global collaboration agreement with JNJ's
Jannsen unit to develop MDG015 for various solid tumors; as part of the deal MGNX received an upfront license fee of $75 mln and is eligible to receive up to an
additional $665 mln in milestone payments as well as royalties. Q2 results on August 3 showed a huge revenue growth rate and a surprise profit, but these were
almost entirely attributable to the Jannsen upfront payment of $75 mln. MGNX ended the quarter with $266 mln in cash, which management believes should fund
operations "into 2018." Note: similar to XNCR above, MGNX is expected to revert back to reporting a loss in Q3, which would automatically remove it from our
rankings.
Huttig Building Products (HBP #21) is a provider of millwork, building materials, and wood products such as exterior and interior doors, windows, patio doors,
frames, and mouldings. Naturally, its success and growth is highly dependent upon the housing market, and in particular, new housing starts. Since bottoming in
April 2009, housing starts have steadily climbed higher, and are now near their highest levels since November 2007. What's particularly encouraging about this
recovery is that first time homebuyers have yet to really enter the market. HBP believes that within this current market, those buyers will come, providing another
leg to this recovery. As the housing market continues to strengthen, HBP has bolstered its growth with its acquisition of BenBilt in April, which is a door fabricator
and wholesale distributor. That acquisition, along with a renewed focus on higher‐margin millwork, has pushed its gross margin and operating profits higher. Going
forward, HBP says it will continue to evaluate accretive acquisitions to augment its organic growth.
Parsley Energy (PE #22), which made its IPO debut in May 2014, is an oil & gas exploration company focused on unconventional oil and natural gas reserves in the
Permian Basin in West Texas, one of the most prolific resource plays in North America. Many of its properties in the Midland Basin are positioned in what the
company believes to be the stacked pay fairway (multiple productive oil & gas formations on the same piece of land). PE made a potentially controversial decision
earlier in 2016 that it would maintain operational momentum even in the face of unsteady commodity prices. PE says this resulted in substantial production growth
and cost compression in Q2. Specifically, PE reported a large EPS beat in Q2, which led to a strong move in the stock. A loss was expected but the company
reported a $0.04 profit thanks in large part to production being much higher that street estimates. PE also closed on some meaningful leasehold acquisitions in both
the Midland Basin and Southern Delaware Basin at increasingly attractive prices. Taking a broader view, over Parsley's nine quarters as a public company, PE has
increased production at a 16% CAGR (much has been organic growth) and built an asset base to support top‐tier growth for years to come. PE is also seen as a low‐
cost operator.
There are nine deletion this week:
AMN Healthcare AHS Industry: Personnel Services
Date Added: 4/25/2016 Add Price: $35.76 Deletion Price: $37.46 Max Gain: 26% Return: 5%
Stock gets slammed lower following last week's Q2 results, taking RS down to 59.
Continental Bldg Prod. CBPX Industry: Building Products
Q2 revenue growth of +6% does not meet our minimum requirement of double‐digit growth.
CyrusOne CONE Industry: Real Estate Investment Trusts
Knocked lower following Q2 results on Aug 1, taking RS down to 60.
Ebix EBIX Industry: Insurance Brokers/Services
Relative Strength declined to 77. Note that EBIX has seen little reaction to this morning's earnings.
Installed Bldg Prod. IBP Industry: Building Products
Slammed lower after the co reported a Q2 miss on Aug 5, taking RS down to 53.
Insperity NSP Industry: Personnel Services
Knocked down after reporting disappointing Q2 results on Aug 1, taking RS down to 58.
Rice Energy RICE Industry: Oil & Gas Production
Q2 EPS of ($0.07) does not meet our minimum requirement of a profit in the most recent quarter.
Shenandoah Telecom SHEN Industry: Major Telecommunications

Sold off sharply following disappointing Q2 results on Aug 5; also, Q2 EPS of ($0.14) does not meet our minimum requirement of a
profit in the most recent quarter.
Yandex YNDX Industry: Internet Software/Services
Relative strength declines to 76.
All times ET.
Monday, August 8
Earnings reports ‐ NPTN after the close (call the following day at 4:30pm), WB after the close (call 9pm).
Presentations & Events ‐ MKSI presents at the Pacific Crest Tech Conference at 4pm ET.
Tuesday, August 9
Earnings reports ‐ BITA before the open (call 8am), LGIH before the open (call 12:30pm), CORR after the close (call the following day at 2pm), CYBR
after the close (call 5pm), PCTY after the close (call 5pm), YRD after the close (call the following day at 8am).
Presentations & Events ‐ CEVA (no time provided) and CARB (11:05am) present at the OpCo Tech Conference. PAYC presents at the Pacific Crest Tech
Conference at 11:30am ET.
Wednesday, August 10
Earnings reports ‐ None.
Presentations & Events ‐ ABMD and CUDA hold their annual meetings, no time provided. Several companies are presenting at the Canaccord Genuity
Growth Conference: CEVA (8am), VASC (8am), MEET (9:30am), PAYC (10am), CRY (12:30pm), CTRL (1:30pm), MGNX (1:30pm), PGND (2pm), XNCR
(3:30pm), CARB (4:30pm). SPSC presents at the OpCo Tech Conference at 2:25pm ET.
Thursday, August 11
Earnings reports ‐ RGLD before the open (call noon).
Presentations & Events ‐ Several companies are presenting at the Canaccord Genuity Growth Conference: SPSC (8am), GRUB (8:30am), ADRO (2pm).
IILG presents at Credit Suisse Gaming Conference, no time provided. HL presents at Jefferies Industrials Conference at 8:40am ET.
Friday, August 12
Earnings reports ‐ None.
Presentations & Events ‐ KCG July 2016 sales to be released.
The following table contains a list of stocks that we believe have the potential to become market leaders. EG components are derived from a quantitative screen
and ranking system that is designed to uncover small‐ to mid‐cap companies that possess a combination of superior 6‐month Relative Strength, strong top‐ and
bottom‐line growth rates, and expanding margins (among other factors). We begin tracking performance of EG components when they are first added to the Top
25. Components are deleted when they fall below rank #100. For more information on how the system works, click on the "User's Guide" link in the Additional
Resources box.
*** If you would like to copy and paste the EG components into your watchlist or spreadsheet, click here to pull up an unformatted ticker list.
Emerging Growth: August 8, 2016
Ranks #1‐25: We begin tracking performance of new additions to the Top 25
1
Yirendai YRD $23.36 Industry: Internet Software/Services
Market Cap (mln) Avg Vol (000) Float (mln) Short Int. Price vs High 6‐Mo RS Q EPS % Q EPS Beat Q Rev % Q Rev Beat
$1,422 579 37 ‐‐ 76% 100 325% 129% 140% 32%
Date Added & Original Profile: 6/27/2016 Price Added: $13.57 % Gain/Loss 72% Most Recent Analysis: 7/13/2016
YRD is an online consumer finance marketplace in China. It matches borrowers with investors to execute loan transactions. It sounds like a Chinese version of
LendingTree (TREE). YRD says China is a very attractive market because consumption is growing quickly but China is underfinanced. YRD makes the point that
it’s just an intermediary, it does not lend its own money, limiting its credit risk. Also, YRD targets more creditworthy borrowers with stable income. YRD is
posting very strong growth (Q1 revs +187%) with robust EBITDA margins (37% in Q1) which has led to a nice move in the stock. However, we view YRD as more
on the speculative side given that it’s a Chinese finance company. Also, global rates are rising which makes loans less attractive and there are concerns about
China’s economy. [6/27/16]
2
Gold Resource GORO $6.49 Industry: Precious Metals
$350 1,104 52 6% 94% 100 900% ‐‐ 11% ‐‐
Date Added & Original Profile: 8/8/2016 Price Added: $6.49 % Gain/Loss 0% Most Recent Analysis: ‐‐
GORO is a gold and silver producer with operations in Oaxaca, Mexico and exploration in Nevada, USA. It focuses on projects that feature low operating costs,
which appears to have helped it keep a debt‐free balance sheet. GORO has a 100% interest in six potential high‐grade gold and silver properties at its
producing Oaxaca, Mexico Mining Unit and exploration properties at its Nevada Mining Unit. GORO’s stock price has been very strong since mid‐January. After
a difficult 2015, commodity prices for silver and gold have improved quite a bit in 2016 due to rising geopolitical risk and the Fed sounding cautious about
raising rates. This has led to higher precious metal prices. On August 2, GORO reported solid Q2 results, boosted by higher gold and silver prices. [8/8/16]
MeetMe MEET $7.30 Industry: Internet Software/Services
$388 2,158 50 7% 97% 99 80% 1122% 48% 7%
MEET is a social network app maker with a significant focus on dating. The company's namesake app is a social network that allows users to meet and chat

3
MEET is a social network app maker with a significant focus on dating. The company's namesake app is a social network that allows users to meet and chat
with new people, although 60% of new users use it for dating. The average age for users is young: median age is 23 years old, 82% of users are under 35, and
66% of users are in the US. In terms of its business model, MEET derives the vast majority of its revenues (90%) from advertising. The company's web revenues
have declined to the point of almost insignificance, but are still a drag on quarterly revenue growth; at this stage the company derives most of its sales from
mobile, which accounted for 88% of total sales in Q1. MEET is profitable and cashflow‐positive, but top‐line growth is moderate, with management seeing
2016 sales growth of just +14% to $63‐66 million. However, MEET expects full year EBITDA to be $23‐26 million (38% of sales) and analysts expect EPS to grow
+136% to $0.33 in 2016. Notably, during the Q1 call management said in order to start monetizing the 33% of its mobile users who are non‐English speaking,
they plan to slowly roll out ads internationally in 2H16, which could be a potential source of upside next year. [6/13/16]
4
Co. de Minas Buenaventura BVN $15.30 Industry: Precious Metals
$4,120 2,159 275 ‐‐ 97% 99 #443% 78% 11% 9%
BVN is Peru's largest, publicly traded, precious metals company and a major holder of mining rights in Peru. BVN is engaged in the mining, processing,
development and exploration of gold and silver and other metals via wholly owned mines as well as through joint exploration projects. Buenaventura currently
operates several mines in Peru and is developing the Tambomayo and San Gabriel projects. The co also owns 43.65% of Minera Yanacocha, a partnership with
mining giant Newmont Mining (NEM). BVN’s stock price has been very strong since mid‐January. After a difficult 2015, commodity prices for silver and gold
have improved quite a bit in 2016 due to rising geopolitical risk and the Fed sounding cautious about raising rates. This has led to higher precious metal
prices. On July 27, BVN reported a solid Q2 beat, boosted by higher gold and silver prices. [8/1/16]
5
Hecla Mining HL $6.87 Industry: Precious Metals
$2,512 9,640 379 9% 102% 99 #240% 43% 72% 23%
HL is a US silver producer with operating mines in Alaska, Idaho, and Mexico and is a gold producer with an operating mine in Quebec, Canada. The company
also has exploration and pre‐development properties in six silver and gold mining districts in the US, Canada and Mexico, and an exploration office and
investments in early‐stage silver exploration projects in Canada. HL’s stock price has been very strong since mid‐January. After a difficult 2015, commodity
prices for silver and gold have improved quite a bit in 2016 due to rising geopolitical risk and the Fed sounding cautious about raising rates has weakened the
dollar somewhat. This has led to higher precious metal prices. HL has focused on growing reserves which led to record production in Q1. In fact, Hecla
expects 10% higher silver production in 2016 on top of last year's record. [6/13/16]
6
SodaStream SODA $28.27 Industry: Electronics/Appliances
$600 407 20 10% 97% 99 118% 79% 19% 13%
SODA is the world’s largest manufacturer of home beverage carbonation systems. After being seen as a hot growth stock in 2013 with the potential to
replicate its success in Europe in order to revolutionize the US carbonated soda market, the stock fell from $78 in mid‐2013 to as low as $12 as recently as Feb
2016. It turned out that US consumers did not want to make their soda at home. SODA was hurt by evolving consumers’ taste away from sugary sodas and it
was hurt because SODA’s soda just didn’t taste that good. In response, SODA recently made a big change: it repositioned itself as a sparkling water brand.
Investors like the repositioning of the brand as the stock has more than doubled since the February lows. A huge Q2 beat in early August is good evidence
that the new strategy is resonating with consumers. [8/8/16]
7
Weibo WB $36.40 Industry: Internet Software/Services
$7,628 1,169 97 ‐‐ 101% 98 #400% ‐10% 22% 2%
WB, frequently referred to as “China’s Twitter”, is a micro‐blogging site that was spun off by Sina (SINA) in 2014. SINA still owns a majority stake, while
Alibaba (BABA) owns a 20% stake in WB and is a major customer as well. Broadly speaking, concerns earlier this year about an economic “hard landing” in China
have abated over the past month as most data has come in better‐than‐feared, sparking some interest in previously battered names like WB. From a
company‐specific perspective, WB reported strong, upside Q4 results on March 2, mainly driven by solid growth in Monthly Average Users (MAUs) at +34%, of
which 83% were mobile users. One soft spot has been that BABA‐related revenue, which accounted for 32% of total revenue in Q4, has been decelerating and
it is expected to do so in 2016. However, non‐BABA advertising and marketing revenue growth (+69% in Q4) has more than off‐set this headwind with its
growth in mobile ads providing a significant lift. Additionally, there has been an influx of “going private” transactions among Chinese ADRs, so, there has
naturally been some speculation that WB could be an acquisition target – particularly from BABA as rumors recently swirled that it may boost its stake.
[4/11/16]
8
Xencor XNCR $21.39 Industry: Biotechnology
$919 314 35 7% 92% 98 #614% ‐‐ 6410% 788%
XNCR is a biotech that uses its proprietary XmAb antibody engineering platform to develop drug candidates to treat autoimmune disorders, cancer, asthma,
and allergic diseases. Basically, it's a platform company that is both developing its own therapeutics and licenses out its technology to larger biopharmas.
XNCR's most advanced drug candidates are both in Phase 2 trials: XmAb5871 for IgG4‐RD and XmAb5574 for asthma/allergy. Prominent partners include AMGN,
NVO, Janssen, MRK, MorphoSys, Boehringer Ingelheim, and ALXN. On June 28 a major catalyst occured when XNCR announced a worldwide collaboration
agreement with NVS to jointly develop XmAb14045 and XmAb13676 (both preclinical). Under the terms of the deal, NVS receives ex‐US rights to the two drug
candidates, while XNCR retains full US rights; NVS also receives rights to develop additional targets. Financially, the deal includes an upfront payment of $150
mln, $2.4 bln in potential milestones, and royalty payments on ex‐US sales. Q2 earnings on Aug 2 showed a huge jump in sales and a surprise profit, but this
was entirely due to the one‐time upfront NVS payment. The stock still jumped on the report however, as mgmt provided more color on the NVS partnership

and noted that they now have enough cash to fund operations through "at least the end of 2019." [8/8/16]
9
Carbonite CARB $12.91 Industry: IT Services
$341 219 20 2% 97% 97 #2000% 660% 57% 21%
CARB provides online data backup for consumers and small‐ and medium‐sized businesses (SMBs). At the time of its 2011 IPO, most of CARB's business was on
the consumer side, which was marked by cut‐throat competition based largely on price (they launched their SMB offering just a year before their IPO). As
competition intensified and pricing pressures mounted, CARB decided to focus on the SMB side. In Dec 2015 the co accelerated this process by acquiring
STX's EVault business, which provided cloud‐based data protection & back‐up for mid‐sized businesses. At a purchase price of $14 mln, the deal was
accretive, added 5,000 customers in North America and Europe, expanded their TAM, and provided CARB with new technology and numerous patents. In
particular, EVault's Disaster Recovery as a Service (DRaaS) was cited as a key growth asset. As it stands now, mgmt sees their gradually declining consumer biz
as a cash cow that helps fund their much faster‐growing SMB segment. Interestingly, CARB saw quite a bit of success in Q1 marketing themselves as
something of a security company, specifically targeting customers who were attacked with "ransomware." On Aug 2, the co reported very strong Q2 results,
driven by growth in its higher‐margin SMB segment. [8/8/16]
10
ANI Pharmaceuticals ANIP $68.15 Industry: Pharmaceuticals: Other
$787 249 8 13% 97% 97 102% 44% 61% 13%
ANIP is a specialty pharma company that has built itself up through a series of accretive product acquisitions. The company focuses on niche and high‐barrier
to entry targets in areas such as controlled substances, anti‐cancer (oncolytics), hormones & steroids, and complex formulations. Approximately 70% of sales
come from generics, 24% from branded products, and <5% from contract manufacturing. ANIP currently has 81 products in development targeting an estimated
total current market of $4.1 billion. On August 4 the company reported very strong Q2 results and raised its 2016 guidance. Management attributed the strong
Q2 performance to several new product launches. Aside from future acquisitions, management cited the July launch of its generic anti‐cancer product and
the anticipated launch of its anti‐infective product as key drivers for Q3; they also reiterated their expectation that revenues and EBITDA will continue to
grow sequentially through 2016 due to new product launches. [8/8/16]
11
Glaukos GKOS $33.53 Industry: Medical Specialties
$1,091 420 15 5% 92% 97 #105% ‐‐ 61% 17%
GKOS is a commercial‐stage MedTech co that sells a portfolio of injectable microstents that treat glaucoma. The co received FDA approval and launched their
first device, the iStent, in the US in July 2012. This device is incredibly tiny, and is is used in combination with cataract surgery. GKOS went public in June
2015 as a commercial‐stage MedTech co with strong sales growth but a history of operating in the red. Following its IPO, the stock did not fare well: on Sep 21
GKOS sold off after a judge ruled that rival Transcend Medical's CyPass Micro‐Stent did not infringe GKOS' patents (GKOS subsequently settled with Transcend
on Oct 29); and the stock sold off again on Jan 13 when the co issued conservative guidance. However, on May 4 GKOS shares surged higher after the co
reported a big Q1 beat‐and‐raise, which featured +57% sales growth and a surprise Q1 profit. While concerns about competition are still an overhang, analysts
expect GKOS to put up +41% sales growth in 2016 and to make significant progress towards profitability. [5/16/16]
12
TTM Technologies TTMI $10.56 Industry: Electronic Components
$1,052 749 68 11% 99% 97 65% 53% 35% 0%
TTMI is the largest printed circuit board (PCB) manufacturer in North America and one of the largest in the world. It focuses on quick‐turn and technologically
advanced (higher margin) PCBs, backplane assemblies and electro‐mechanical products. Increasing demand for smaller electronic devices with more features is
driving the need for increasingly complex PCBs. In 2015, TTMI made a major acquisition when it acquired Viasystems Group, which boosted TTMI’s presence in
the lucrative and growing automotive sector and it strengthened TTMI’s position in several other areas. TTMI has been rallying since late July when it
reported a large Q2 beat with sizeable upside guidance. TTMI saw a rebound in its cellular and communications end markets and its aerospace segment
posted a quarterly record in revenue. [8/1/16]
13
LogMeIn LOGM $82.98 Industry: Internet Software/Services
$2,117 328 24 7% 96% 97 40% 8% 28% 2%
Date Added & Original Profile: 8/1/2016 Price Added: $84.69 % Gain/Loss ‐2% Most Recent Analysis: 7/27/2016
LOGM is a SaaS provider of remote PC access & support software, with a traditional focus on IT professionals in the SMB segment. Historically, LOGM has
operated using the "freemium" model: speeding adoption of its products with free versions, and then upselling users to paid versions. The co's flagship
product is LogMeIn, which is a relatively mature offering that allows users to remotely log into and manage their PCs from anywhere; in recent quarters
LOGM's main growth driver has been the monetization of its popular online meeting/collaboration program Join.Me. On July 26 LOGM announced a
transformative merger with Citrix's GoTo division, which is best‐known for its GoToMeeting remote collaboration service. For LOGM the deal expands their
TAM by opening up the enterprise segment (which GoTo has traditionally served) and by shifting the mix towards the much larger and growing collaboration
market, while at the same time lessening their dependence on remote access. Financially, the deal triples LOGM's rev to $1 bln, and the combined co is
expected to have an adjusted EBITDA margin of 35% and a FCF margin of 25%. On the downside, the combined co will be growing at a slower pace, and the
merger isn't expected to close until 1Q17. [8/1/16]
GrubHub GRUB $38.96 Industry: Internet Software/Services
$3,284 2,119 83 27% 99% 97 35% 22% 37% 5%

14
GRUB is the largest online and mobile platform for takeout and delivery of takeout restaurant orders. While GRUB is a first‐mover in this segment, competition
has intensified in recent years, so the company has been looking to reignite growth by spending heavily on building out its delivery service that targets chain
restaurants. While profit margins are much higher for their service without delivery, the company says that adding delivery is a key part of their plan for
accelerating top‐line growth. While quarterly growth rates have slowed down from the triple‐digits at the time of their 2014 IPO to +27% in the most recent
quarter, the co is still quite profitable, generates a good amount of cash, and has no debt. Also, GRUB sees a lot of industry growth potential as online/app
orders represent just 5% of the entire takeout/delivery market. [6/20/16]
15
Supreme Industries STS $15.66 Industry: Trucks/Construction/Farm Machinery
$270 289 15 6% 88% 96 85% 50% 12% ‐‐
STS is a manufacturer of specialized commercial vehicles including truck bodies, trolleys and specialty vehicles. Most of its products are attached to light‐and‐
medium duty truck chasses. The co's products include truck bodies for dry‐freight transportation for a wide variety of commercial, agricultural, and
construction use. For example, STS sells cargo vans, armored trucks, refrigerated vans, trolleys etc. STS divested its struggling shuttle bus business in early
2014 in order to focus on its core truck business. The stock jumped in mid‐Feb on a very strong Q4 report which was followed up by a solid Q1 report in late
April. STS has been seeing good demand in the medium duty work truck sector. We caution that STS’ business is highly cyclical, there is little analyst
coverage, it’s thinly traded and since they do not guide, its results can be pretty choppy from quarter‐to‐quarter. With that said, its business is performing
well these days. [5/9/16]
16
BioTelemetry BEAT $21.07 Industry: Medical Specialties
$586 446 26 3% 99% 96 67% 15% 18% 5%
BEAT provides cardiac monitoring services, through its Mobile Cardiac Outpatient Telemetry (MCOT) service. Its MCOT service uses a lightweight patient‐worn
sensor attached to electrodes that capture ECG data on a compact wireless handheld monitor. The stock jumped in late April on a very strong Q1 earnings
report with record revenue. The rollout of its new CardioKey monitor has gone very well. Also, BEAT has been pretty active on the M&A front with a goal of
shifting away from an MCOT‐only mindset, to a more comprehensive portfolio. BEAT is also benefitting from a shift in the cardiac monitoring market toward
increased improved diagnostic accuracy. BEAT believes its MCOT service has no equal in terms of accuracy. Finally, BEAT is benefitting from increased
awareness about AFib, driven in large part by advertising of medications like Xarelto and Eliquis. This inevitably drives increases in testing and monitoring.
[5/2/16]
17
MacroGenics MGNX $30.94 Industry: Biotechnology
$1,094 268 31 8% 80% 96 #258% ‐‐ 1101% 196%
MGNX is a clinical‐stage biopharma focused on developing antibody‐based therapeutics for the treatment of cancer and autoimmune diseases. The co's
proprietary technologies include its Dual Affinity Re‐Targeting (DART) platform, which has produced six molecules that are being evaluated in clinical studies,
and its Fc Optimization platform (which takes a similar approach as XNCR's platform). MGNX's most advanced product candidate is margetuximab, which is in
trials for two separate indications: HER2‐positive metastatic breast cancer (just beginning Phase 3) and gastric cancer (Phase 1b/2). The company also has
multiple product candidates from its DART platform and its B7‐H3 franchise that are in pre‐clinical and Phase 1 studies. The company has partnerships with
Pfizer, Boehringer Ingelheim, Gilead Sciences, and Takeda. Recently, on May 18 MGNX announced a global collaboration agreement with JNJ's Jannsen unit to
develop MDG015 for various solid tumors; as part of the deal MGNX received an upfront license fee of $75 mln and is eligible to receive up to $665 mln in
milestone payments as well as royalties. Q2 results on Aug 3 showed a huge revenue growth rate and a surprise profit, but these were almost entirely
attributable to the Jannsen upfront payment of $75 mln. MGNX ended the quarter with $266 mln in cash, which mgmt believes should fund operations "into
2018." [8/8/16]
18
Richmont Mines RIC $10.57 Industry: Precious Metals
$662 394 57 1% 92% 96 41% ‐52% 28% ‐1%
RIC is a Canadian gold mining company operating three properties, including Island Gold in Ontario and Beaufor and Camflo Mill in Quebec. Gold and precious
metals have been strong this year due to the volatility in the market and concerns about the health of the global economy. This unease has generated
heightened investor interest in gold‐related assets, including developers and producers like RIC. From a company‐specific standpoint, RIC’s Island Gold mine
churned out record production of 26,589 ounces in 1Q16, spiking 147% y/y as a result of higher than expected grades and strong throughput. Due to the
robust production at Island, RIC commented that it is on track to hit the high end of its 2016 production guidance of 87,000‐89,000 ounces. It is also notable
that RIC has been generating positive cash flows, which is not necessarily common for a gold producer, and has a solid balance sheet with limited long term
debt and nearly $50 mln in cash. [6/6/16]
19
Shutterstock SSTK $57.63 Industry: Internet Software/Services
$2,011 485 18 23% 98% 96 16% 18% 19% 0%
SSTK owns the well‐known marketplace for licensed images. The co's library of commercial images & other media is used primarily by creative professionals in
corporate marketing, advertising, and publishing depts. At this stage, the images business is mature and marked by intense competition, so in recent years
SSTK has been augmenting its service by acquiring other forms of media such as licensed videos, music, editorial content, and workflow tools in order to
sustain its growth. 2015 was a tough year for the co: in Dec 2014 ADBE acquired SSTK competitor Fotolia, which created legitimate investor anxiety that

ADBE could begin to take share. In addition, last year SSTK suffered from some sustained currency headwinds (2/3 of its customers are outside the US), and
at the same time key metrics such as paid downloads and customer acquisition moderated. Mgmt has steadily maintained that they have not seen any
pressure yet from Adobe, and the co's 1Q16 report on May 4 further reassured investors, as it featured a nice EPS beat, solid trends in all metrics, and a FY16
guidance reaffirm. [7/18/16]
20
Royal Gold RGLD $85.06 Industry: Precious Metals
$5,448 961 65 5% 97% 96 12% 8% 26% ‐3%
RGLD is not an actual gold miner, rather it acquires interests in royalties. Its portfolio consists of interests in 193 properties, including 38 producing mines and
24 development stage projects. RGLD typically pays a front end payment to help finance projects without assuming any responsibility for the actual mining
operation. Therefore, it generates royalty revenue at much lower operating costs than many precious metals operators, enabling it to generate stronger
operating profits and return more capital to investors via its dividend. Since the beginning of 2016, gold and silver prices have soared higher as investors have
looked for safe havens due to volatility in the stock market. As central banks around the world continue to push interest rates lower in an effort to stoke
economic growth and inflation, paper currencies weaken, driving the price of precious metals higher. Meanwhile, RGLD has been heavily investing in new
projects, acquiring revenue streams at four new mines: Pueblo Viejo, Wassa and Prestea, and Andacollo. These additions have increased its total gold
interests to 86.1 million ounces from 73.7 million at the end of 2014, and its silver interests to 779.5 million from 764.0 million a year ago. Looking ahead, RGLD
has another potential revenue stream lined up due to its $100 million investment at Rainy River, which was 35% completed at the end of April. [5/2/16]
21
Huttig Building Products HBP $6.22 Industry: Wholesale Distributors
$153 217 19 0% 89% 95 10% ‐‐ 13% ‐‐
HBP is a provider of millwork, building materials, and wood products such as exterior and interior doors, windows, patio doors, frames, and mouldings.
Naturally, its success and growth is highly dependent upon the housing market, and in particular, new housing starts. Since bottoming in April 2009, housing
starts have steadily climbed higher, and are now near their highest levels since November 2007. What's particularly encouraging about this recovery is that
first time homebuyers have yet to really enter the market. HBP believes that within this current market, those buyers will come, providing another leg to this
recovery. As the housing market continues to strengthen, HBP has bolstered its growth with its acquisition of BenBilt in April, which is a door fabricator and
wholesale distributor. That acquisition, along with a renewed focus on higher‐margin millwork, has pushed its gross margin and operating profits higher. Going
forward, HBP says it will continue to evaluate accretive acquisitions to augment its organic growth. [8/8/16]
22
Parsley Energy PE $32.97 Industry: Oil & Gas Production
$5,565 2,809 155 10% 100% 95 #500% ‐‐ 37% 9%
PE is an oil & gas exploration company focused on unconventional oil and natural gas reserves in the Permian Basin in West Texas. PE made a potentially
controversial decision earlier in 2016 that it would maintain operational momentum even in the face of unsteady commodity prices. PE says this resulted in
substantial production growth and cost compression in Q2. Specifically, PE reported a large EPS beat in Q2, which led to a strong move in the stock.
Production was much higher that street estimates. PE also closed on some meaningful leasehold acquisitions at increasingly attractive prices. Taking a broader
view, over Parsley's nine quarters as a public company, PE has increased production at a 16% CAGR (much has been organic growth) and built an asset base to
support top‐tier growth for years to come. PE is also seen as a low‐cost operator. [8/8/16]
23
Barracuda Networks CUDA $21.77 Industry: IT Services
$1,147 682 24 7% 73% 95 122% 84% 11% 3%
CUDA sells a suite of security and storage appliances and services. CUDA is in the early stages of a turnaround. The key thing for investors to understand is
that CUDA is not a "next‐gen" security vendor like FEYE, PANW, or IMPV. CUDA has built its business on being an "affordable" provider of security & storage
products, with a heavy emphasis on subscriptions, and it doesn't compete in the next‐gen/high‐end security market. The stock was hammered in 2015 after
it reported three rough quarters in a row. However, the co has begun to revamp its product line towards faster‐growing cloud‐ and virtual‐based products,
and the co reported much better than feared 4Q16 (Feb) results on April 26. While its 1Q17 (May) report on July 7 showed a continued deceleration in sales
growth (to +11%), the beat and triple‐digit EPS growth was reassuring. [7/18/16]
24
Gigamon GIMO $44.71 Industry: Packaged Software
$1,574 751 30 7% 95% 95 88% 25% 46% 7%
GIMO sells appliances & software that routes network traffic more intelligently, efficiently, and securely. The company sells into three core verticals:
enterprise (59% of Q1 sales), service provider (25%), and federal (16%). This June 2013 IPO began to implode in early 2014 due to a series of disappointing
outlooks, which were accompanied by vague explanations that didn't sit well with investors. Yet mgmt's turnaround efforts eventually bore fruit, with growth
beginning to reaccelerate over the course of 2015. During this period, security became the key driver of the business. Company reported another clean beat‐
and‐raise for Q1 on April 28. In recent quarters, mgmt has said that security platform sales were having a big impact on new deal size: with the launch of their
GigaSECURE platform in 3Q15, orders for the security platform from new customers were much larger than for other new customer orders, and roughly 60% of
opportunities are now directly associated with security. [6/27/16]
Teligent TLGT $8.29 Industry: Household/Personal Care
$442 316 41 23% 90% 94 #150% ‐‐ 93% 7%

25
TLGT was previously known as IGI Labs (IG) until the co changed its name and ticker to Teligent (TLGT) in Oct 2015. TLGT is a small‐cap generic pharma that
had been an unprofitable contract manufacturing & development company until 2010, when it began to transform itself into a generic pharma co specializing
in topical treatments. In 2013 sales growth accelerated markedly, sparking a big run in the stock; but the rally ended in April 2015 following poor 1Q15 results
& guidance due to pricing pressures and mkt share losses in its flagship econazole product (which at the time accounted for roughly 50% of total sales). In
late‐2015 TLGT made several acquisitions that bolstered its higher‐margin injectable products line. As it stands now, the company has 14 products on the
market: 10 topical and 4 injectable. The co has 33 ANDAs on file in the US, with a target to submit 15 ANDAs to the FDA and 8 to Health Canada in 2016. In
other words, TLGT has a lot of shots on goal this year and next. The co's results have been uneven and mgmt is spending heavily on R&D, but analysts expect
strong 40+% rev growth in both 2016 & 2017 and a return to profitability this year. [7/11/16]
Ranks #26‐100: We continue to track performance until they drop below Rank #100
Rank Name Ticker Industry Mkt Cap 6‐Mo RS Q EPS % Q Rev % Date Added % Gain/Loss
#26 Paycom Software PAYC Packaged Software $3,081 94 110% 51% ‐‐ ‐‐
#27 Hudson Technologies HDSN Environmental Services $160 94 75% 21% 7/25/2016 ‐7%
#28 MercadoLibre MELI Internet Software/Services $7,638 94 68% 29% ‐‐ ‐‐
#29 Ubiquiti Networks UBNT Telecoms Equipment $4,114 94 38% 28% ‐‐ ‐‐
#30 CorEnergy Infrastructure CORR Investment Trusts $355 94 28% 43% 5/16/2016 33%
#31 Central Garden & Pet CENTA Consumer Sundries $1,283 94 26% 12% ‐‐ ‐‐
#32 FormFactor FORM Electronic Equipment $743 94 18% 12% ‐‐ ‐‐
#33 Supernus Pharmaceuticals SUPN Pharmaceuticals: Other $1,144 93 500% 44% 5/23/2016 25%
#34 XPO Logistics XPO Trucking $4,052 93 #363% 203% ‐‐ ‐‐
#35 Dycom Industries DY Engineering & Construction $3,033 93 86% 35% 5/31/2016 14%
#36 Control4 CTRL Electronic Equipment $253 93 44% 34% ‐‐ ‐‐
#37 Duluth DLTH Apparel/Footwear $921 93 43% 21% ‐‐ ‐‐
#38 Alarm.com ALRM IT Services $1,340 92 200% 28% 6/27/2016 24%
#39 Oclaro OCLR Electronic Components $708 92 #283% 22% ‐‐ ‐‐
#40 Vanda Pharmaceuticals VNDA Biotechnology $536 92 #200% 31% ‐‐ ‐‐
#41 Drew Industries DW Miscellaneous Manufacturing $2,289 92 78% 22% 5/23/2016 30%
#42 Paylocity PCTY Packaged Software $2,410 92 91% 49% ‐‐ ‐‐
#43 American Homes 4 Rent AMH Real Estate Investment Trusts $5,349 92 62% 44% ‐‐ ‐‐
#44 Veeva Systems VEEV IT Services $5,141 92 25% 33% 5/31/2016 17%
#45 RetailMeNot SALE Advertising/Marketing $495 92 11% 21% ‐‐ ‐‐
#46 CEVA Inc CEVA Semiconductors $649 91 250% 19% ‐‐ ‐‐
#47 Silicon Motion Technology SIMO Semiconductors $1,865 91 69% 62% 5/23/2016 27%
#48 Argan AGX Industrial Specialties $697 91 62% 52% 6/13/2016 11%
#49 LendingTree TREE Finance/Rental/Leasing $1,296 91 63% 71% ‐‐ ‐‐
#50 CyberArk Software CYBR IT Services $1,887 91 44% 43% ‐‐ ‐‐
#51 Energy Recovery ERII Electrical Products $624 90 #117% 14% ‐‐ ‐‐
#52 Rice Midstream Partners RMP Oil & Gas Production $1,686 90 81% 136% 4/25/2016 29%
#53 Horizon Pharma HZNP Pharmaceuticals: Other $3,223 90 44% 81% ‐‐ ‐‐
#54 SPS Commerce SPSC Packaged Software $1,108 90 28% 22% ‐‐ ‐‐
#55 Vascular Solutions VASC Medical Specialties $802 90 14% 10% ‐‐ ‐‐
#56 BG Staffing BGSF Personnel Services $170 89 45% 26% 7/25/2016 ‐6%
#57 RADCOM RDCM Electronic Equipment $189 88 186% 49% ‐‐ ‐‐
#58 CryoLife CRY Medical Specialties $497 88 133% 33% ‐‐ ‐‐
#59 RingCentral RNG Data Processing Services $1,737 88 #140% 30% ‐‐ ‐‐
#60 TerraForm Power TERP Alternative Power Generation $1,098 88 #126% 191% ‐‐ ‐‐
#61 Patrick Industries PATK Building Products $975 88 41% 35% 7/5/2016 1%
#62 Videocon d2h VDTH Cable/Satellite TV $972 87 #125% 17% ‐‐ ‐‐
#63 Avid Technology AVID Computer Peripherals $298 87 868% 22% ‐‐ ‐‐
#64 Omega Protein OME Agricultural Commodities $545 87 44% 21% ‐‐ ‐‐
#65 Omnicell OMCL Health Industry Services $1,366 87 36% 53% ‐‐ ‐‐
#66 Nutrisystem NTRI Other Consumer Services $862 87 32% 15% ‐‐ ‐‐
#67 Navigant Consulting NCI Misc. Commercial Services $934 87 27% 12% ‐‐ ‐‐
#68 NeoPhotonics NPTN Electronic Components $566 87 15% 22% ‐‐ ‐‐
#69 Masimo MASI Medical Specialties $2,763 86 58% 12% ‐‐ ‐‐
#70 MarketAxess MKTX Investment Banks/Brokers $6,127 86 38% 28% ‐‐ ‐‐
#71 Interval Leisure Group IILG Misc. Commercial Services $2,254 86 24% 71% ‐‐ ‐‐
#72 Plantronics PLT Telecoms Equipment $1,688 86 13% 10% ‐‐ ‐‐
#73 Align Technology ALGN Medical Specialties $7,351 85 59% 29% ‐‐ ‐‐
#74 CONE Midstream Partners CNNX Oil & Gas Pipelines $997 85 56% 22% 4/11/2016 30%
#75 BMC Stock BMCH Building Products $1,302 85 28% 144% ‐‐ ‐‐
#76 Quotient Technology QUOT Advertising/Marketing $1,105 84 #740% 20% ‐‐ ‐‐
#77 Inogen INGN Medical Specialties $1,082 84 47% 27% ‐‐ ‐‐
#78 ABIOMED ABMD Medical Specialties $5,175 84 45% 40% ‐‐ ‐‐
#79 Press Ganey PGND IT Services $2,124 84 36% 18% ‐‐ ‐‐
#80 William Lyon Homes WLH Homebuilding $550 84 19% 28% ‐‐ ‐‐
#81 MKS Instruments MKSI Electronic Equipment $2,522 84 16% 50% ‐‐ ‐‐
#82 LGI Homes LGIH Homebuilding $667 83 73% 35% 7/5/2016 2%
#83 Astec Industries ASTE Trucks/Construction $1,385 83 55% 10% ‐‐ ‐‐
#84 Aduro BioTech ADRO Biotechnology $1,007 83 #106% 294% ‐‐ ‐‐
#85 M/I Homes MHO Homebuilding $556 83 21% 25% ‐‐ ‐‐

#86 Cabot Microelectronics CCMP Industrial Specialties $1,211 82 103% 11% ‐‐ ‐‐
#87 Fair Isaac FICO Packaged Software $3,983 82 61% 14% ‐‐ ‐‐
#88 Stoneridge SRI Auto Parts: OEM $489 82 64% 13% ‐‐ ‐‐
#89 Five Below FIVE Discount Stores $2,768 82 50% 25% ‐‐ ‐‐
#90 Smith & Wesson SWHC Miscellaneous Manufacturing $1,664 82 47% 22% ‐‐ ‐‐
#91 NuVasive NUVA Medical Specialties $3,151 82 29% 16% ‐‐ ‐‐
#92 Black Knight Financial BKFS IT Services $2,711 82 21% 10% ‐‐ ‐‐
#93 Alexandria Real Estate ARE Real Estate Investment Trusts $8,687 82 19% 10% ‐‐ ‐‐
#94 LifeVantage LFVN Pharmaceuticals: Generic $186 81 100% 24% 6/13/2016 ‐2%
#95 Bluerock Residential Growth BRG Real Estate Investment Trusts $279 81 100% 84% ‐‐ ‐‐
#96 CommVault Systems CVLT Packaged Software $2,274 81 75% 10% ‐‐ ‐‐
#97 TRI Pointe TPH Homebuilding $2,206 81 35% 26% ‐‐ ‐‐
#98 Bitauto BITA Internet Software/Services $1,789 81 33% 48% ‐‐ ‐‐
#99 Sabra Health Care REIT SBRA Real Estate Investment Trusts $1,599 81 12% 31% ‐‐ ‐‐
#100 KCG Holdings KCG Investment Banks/Brokers $1,305 80 6292% 17% ‐‐ ‐‐
Sources: Briefing.com, FactSet
Lead Analyst & Developer of the Emerging Growth system: Jim Busch
Fundamental Analysts: Jim Busch, Robert Reid, and Dennis Hobein.
The Emerging Growth Stocks column can be found on the Investing & Trading menu. On Live In Play, all of the Emerging Growth Stocks content can be searched for,
and have alerts generated by, the "GROWX" ticker. Comments or suggestions? Please send them to emerginggrowth@briefing.com.
Disclaimer
Briefing.com, Inc. ("Briefing.com") is not a registered investment adviser. This document does not constitute an offer or solicitation to buy or sell any securities discussed herein, or to offer for compensation any
investment advisory services or any securities brokerage services. No person other than a current subscriber in good standing with Briefing.com may rely on any information contained herein. Briefing.com is not
acting as a broker or dealer under any federal or state securities laws.
Reproduction or editing by any means, in whole or in part, or any unauthorized use, disclosure or redistribution of the Briefing.com content herein without the express written permission of Briefing.com is strictly
prohibited. The information contained in this report has been obtained from sources which Briefing.com believes to be reliable; however, Briefing.com does not guarantee the accuracy, completeness or timeliness of
any information or analysis contained in the report. The information and analysis herein are provided "as is" and without warranty of any kind, either expressed or implied. The performance of Briefing.com's past
recommendations and model results are not a guarantee of future results. Users assume the entire cost and risk of any investment decision they choose to make, Briefing.com shall not be liable for any loss or
damages resulting from the use of the information contained in the report, or for error of transmission of information, or for any third party claims of any nature. Nothing herein shall constitute a waiver or limitation of
any person's rights under relevant federal or state securities laws.
Briefing.com offers a wide range of premium services. Free trial requests can be made via our institutional sales or customer service departments.

JBusch - Emerging Growth Stocks

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Similar to JBusch - Emerging Growth Stocks

Similar to JBusch - Emerging Growth Stocks (20)

JBusch - Emerging Growth Stocks